Nectar Lifesciences Share Price
12.19+0.02 (+0.16%)
-15.93% past 1 Year
Nectar Lifesciences (Nectar) is a global pharmaceutical company specializing in Cephalosporins. The company is the world’s leading producer of Cefixime Trihydrate, Cefuroxime Axetil, Cefpodoxime Proxetil and Sterile APIs.
Corporate filings & documents
Announcements
Please find attached herewith letter sent to the members pursuant to Regulation 36(1)(b)of the SEBI (LODR) Regulations 2015.
1 week agoPlease find attached herewith letter sent to the members pursuant to Regulation 36(1)(b)of the SEBI (LODR) Regulations 2015.
1 week agoPlease find attached herewith newspaper publication of notice of 31st Annual General Meeting e-voting book closure & other information.
2 weeks agoPlease find attached herewith newspaper publication of notice of 31st Annual General Meeting e-voting book closure & other information.
2 weeks agoPursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith copy of Annual Report for the financial year ended on March 31 2026
2 weeks agoPursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith copy of Annual Report for the financial year ended on March 31 2026
2 weeks agoPlease find attached herewith Notice of 31st AGM for the Financial Year 2025-26 is scheduled to be held on Friday September 18 2026
2 weeks agoPlease find attached herewith Notice of 31st AGM for the Financial Year 2025-26 is scheduled to be held on Friday September 18 2026
2 weeks agoPlease find attached herewith newspaper publication of notice to the shareholders regarding 31st AGM of the Company to be held on Friday September 18 2026 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) and other information as required under circulars issued by Ministry of Corporate Affairs
2 weeks agoPlease find attached herewith newspaper publication of notice to the shareholders regarding 31st AGM of the Company to be held on Friday September 18 2026 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) and other information as required under circulars issued by Ministry of Corporate Affairs
2 weeks agoPlease find attached herewith copies of newspaper publication of financial results ended on June 30 2026.
2 weeks agoPlease find attached herewith copies of newspaper publication of financial results ended on June 30 2026.
2 weeks agoPlease find attached herewith letter of change in corporate office of the Company
2 weeks agoPlease find attached herewith letter of change in corporate office of the Company
2 weeks agoAGM to be held on September 18 2026 and book closure date for the same is from September 12 2026 to September 18 2026(both days inclusive). The Cut-off date to ascertain the eligibility of members for remote e-voting and/ or polling/ e-voting at AGM is September 11 2026 i.e. the date prior to the commencement of book closure
2 weeks agoAGM to be held on September 18 2026 and book closure date for the same is from September 12 2026 to September 18 2026(both days inclusive). The Cut-off date to ascertain the eligibility of members for remote e-voting and/ or polling/ e-voting at AGM is September 11 2026 i.e. the date prior to the commencement of book closure
2 weeks agoWe wish to inform you that the board of directors of Nectar Lifesciences Limited (Company) in their meeting held on August 14 2026 have inter-alia noted decided and approved the following matters:1. To convene the 31st AGM of the members of the Company on Friday September 18 2026;2. To close the register of members and share transfer books from September 12 2026 to September 18 2026 (both days inclusive) for the purpose of AGM. Accordingly the cut-off date to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM is September 11 2026 i.e. the date prior to the commencement of book closure; and3. The re-appointment of Mr. Sanjiv Goyal (DIN: 00002841) director who retire by rotation in the forthcoming AGM;
2 weeks agoWe wish to inform you that the board of directors of Nectar Lifesciences Limited (Company) in their meeting held on August 14 2026 have inter-alia noted decided and approved the following matters:1. To convene the 31st AGM of the members of the Company on Friday September 18 2026;2. To close the register of members and share transfer books from September 12 2026 to September 18 2026 (both days inclusive) for the purpose of AGM. Accordingly the cut-off date to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM is September 11 2026 i.e. the date prior to the commencement of book closure; and3. The re-appointment of Mr. Sanjiv Goyal (DIN: 00002841) director who retire by rotation in the forthcoming AGM;
2 weeks agoPlease find attached herewith the financial results for the quarter ended on June 30 2026.
2 weeks agoPlease find attached herewith the financial results for the quarter ended on June 30 2026.
2 weeks agoNectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended on June 30 2026 and matters related thereto and other business matters if any.
3 weeks agoNectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended on June 30 2026 and matters related thereto and other business matters if any.
3 weeks agoPlease find attached herewith letter of Resignation of Non-Executive Non-Independent Director of the Nectar LifesciencesLimited
4 weeks agoPlease find attached herewith letter of Resignation of Non-Executive Non-Independent Director of the Nectar LifesciencesLimited
4 weeks agoPlease find attached herewith letter of Sale and Surrender of Leasehold Rights in Land Situated in Jammu
1 month agoPlease find attached herewith letter w.r.t.: Update on Slump Sale
1 month agoPlease find attached herewith letter w.r.t.: Update on Slump Sale
1 month agoWe wish to inform you that the board of directors of Nectar Lifesciences Limited (Company) has change the registered office of the Company
1 month agoWe wish to inform you that the board of directors of Nectar Lifesciences Limited (Company) has change the registered office of the Company
1 month agoPlease find attached herewith the certificate as per caption regulations
2 months agoPlease find attached herewith the certificate as per caption regulations
2 months agoTrading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015
2 months agoTrading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015
2 months agoPlease find attached herewith copy of newspaper publication as per Section 124(6) of Companies Act 2013
2 months agoPlease find attached herewith copy of newspaper publication as per Section 124(6) of Companies Act 2013
2 months agoPlease find attached herewith the copy of newspapers for publication of financial results of the Company for the quarter and financial year ended on March 31 2026
3 months agoFinancial Results for the Year 2025-26
3 months agoFinancial Results for the Year 2025-26
3 months agoNectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results for the Financial Year 2025- 26 Financial Statement of the Company for the Financial Year 2025-26 and matters related thereto
3 months agoNectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results for the Financial Year 2025- 26 Financial Statement of the Company for the Financial Year 2025-26 and matters related thereto
3 months agoPlease find attached herewith letter w.r.t.: Update on Slump Sale
4 months agoPlease find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations 2015
4 months agoPlease find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations 2015
4 months agoPlease find attached herewith Annual Secretarial Compliance Report for the year ended on March 31 2026
4 months agoPlease find attached herewith Annual Secretarial Compliance Report for the year ended on March 31 2026
4 months agoPlease find attachment.
4 months agoPlease find attachment.
4 months agoPlease find attached herewith the certificate as per captioned regulations
5 months agoTrading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015
5 months agoTrading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015
5 months agoAnnual reports
Concalls & investor presentations
Jan 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
2020-09-18
Dividend
0.05
2020-09-11
Dividend
0.05
2019-09-19
Dividend
0.05
2018-09-19
Dividend
0.05
2017-09-20
Dividend
0.05
2016-09-22
Dividend
0.1
2015-09-22
Dividend
0.1
2014-08-21
Dividend
0.1
2013-09-19
Dividend
0.1
2012-09-20
Dividend
0.1
2011-09-21
Dividend
0.1
Company details
Registered office
Showroom No. 8, First Floor Patiala Complex, Barwala Road Dera Bassi SAS Nagar Dist Punjab PIN: 140507 Tel No: 01762-534001 / 534002 Fax No: 01762-531833 Email: [email protected] Internet: www.neclife.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Sanjaymohan Singh Rawat, Company Secretary & Compliance Officer
Sanjiv Goyal, Chairman & Managing Director
Sanjiv Goyal, Chairman & Managing Director
Rupinder Tewari, Non Executive Independent Director
Kuldip Kumar Bhasin, Non Executive Independent Director
Indu Pal Kaur, Non Executive Independent Director
Sushil Kapoor, Whole Time Director - Finance & Chief Financial Officer
Gunmala Suri, Non Independent & Non Executive Director
Details
BSE 532649
NSE NECLIFE
ISIN INE023H01027